Literature DB >> 1370358

Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3.

S E Artandi1, K L Calame, S L Morrison, V R Bonagura.   

Abstract

A combination of site-directed mutagenesis and exon exchange has been used to further define the structure on IgG recognized by monoclonal IgM rheumatoid factors (RFs) from patients with Waldenstrom macroglobulinemia. Most of these RFs bound IgG1, -2, and -4 but not IgG3. For these RFs, His-435 is a critical residue for binding and replacing it with arginine, the residue present in IgG3, destroys or reduces RF binding. However, additional polymorphic sequences in both the heavy-chain constant-region domains (CH) 2 and 3 are important for RF binding. Among the important residues in CH2 are amino acids 252-254 and 309-311, which are conserved among IgG isotypes and comprise two loops of amino acids on the surface of the domain. Therefore, at least three regions, two from CH2 and one from CH3, contribute significantly to the epitope recognized by the RFs. Although this epitope contains many of the same residues as the staphylococcal protein A binding site on IgG, the binding specificities of staphylococcal protein A and monoclonal RFs are not identical. Sera from patients with rheumatoid arthritis contain antibodies directed not only at this epitope but also at other sites on IgG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370358      PMCID: PMC48182          DOI: 10.1073/pnas.89.1.94

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The latex-fixation reaction in nonrheumatic diseases.

Authors:  E DRESNER; P TROMBLY
Journal:  N Engl J Med       Date:  1959-11-12       Impact factor: 91.245

2.  Hidden rheumatoid factors with specificity for native gamma globulins.

Authors:  J C Allen; H G Kunkel
Journal:  Arthritis Rheum       Date:  1966-12

3.  Immunogenic and antigenic epitopes of immunoglobulins--VII. The topographical distribution of Fc gamma epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435.

Authors:  M I Nik Jaafar; J A Lowe; N R Ling; R Jefferis
Journal:  Mol Immunol       Date:  1984-02       Impact factor: 4.407

4.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

Authors:  J Deisenhofer
Journal:  Biochemistry       Date:  1981-04-28       Impact factor: 3.162

Review 5.  Rheumatoid factor.

Authors:  P P Chen; S Fong; D A Carson
Journal:  Rheum Dis Clin North Am       Date:  1987-12       Impact factor: 2.670

6.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Studies on the antigenic determinants in the self-association of IgG rheumatoid factor.

Authors:  F A Nardella; D C Teller; M Mannik
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

8.  Rheumatoid factors and secondary immune responses in the mouse. I. Frequent occurrence of hybridomas secreting IgM anti-IgG1 autoantibodies after immunization with protein antigens.

Authors:  J Van Snick; P Coulie
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

9.  Rheumatoid factor-like immunoglobulin M protects previously uninfected rat pups and dams from Trypanosoma lewisi.

Authors:  A B Clarkson; G H Mellow
Journal:  Science       Date:  1981-10-09       Impact factor: 47.728

10.  Immunogenic and antigenic epitopes of immunoglobulins. VIII. A human monoclonal rheumatoid factor having specificity for a discontinuous epitope determined by histidine/arginine interchange as residue 435 of immunoglobulin G.

Authors:  R Jefferis; M I Nik Jaafar; M Steinitz
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

View more
  16 in total

1.  Rheumatoid factors: where are we now?

Authors:  A I Soltys; J S Axford; B J Sutton
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

2.  Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Authors:  Jeremy Sokolove; Dannette S Johnson; Lauren J Lahey; Catriona A Wagner; Danye Cheng; Geoffrey M Thiele; Kaleb Michaud; Harlan Sayles; Andreas M Reimold; Liron Caplan; Grant W Cannon; Gail Kerr; Ted R Mikuls; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

3.  Autoreactive sites of human lambda light chain mapped by comprehensive peptide synthesis.

Authors:  H Kaymaz; J J Marchalonis
Journal:  J Protein Chem       Date:  1993-12

4.  Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity.

Authors:  Mitsunori Shiroishi; Yuji Ito; Kenta Shimokawa; Jae Man Lee; Takahiro Kusakabe; Tadashi Ueda
Journal:  J Biol Chem       Date:  2018-03-09       Impact factor: 5.157

Review 5.  Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.

Authors:  Vincent R Bonagura; Lynda J Hatam; David W Rosenthal; James A de Voti; Fung Lam; Bettie M Steinberg; Allan L Abramson
Journal:  APMIS       Date:  2010-06       Impact factor: 3.205

6.  Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.

Authors:  Yoichi Nakayama; Ryu Watanabe; Kosaku Murakami; Koichi Murata; Masao Tanaka; Hiromu Ito; Wataru Yamamoto; Kosuke Ebina; Kenichiro Hata; Yuri Hiramatsu; Masaki Katayama; Yonsu Son; Hideki Amuro; Kengo Akashi; Akira Onishi; Ryota Hara; Keiichi Yamamoto; Koichiro Ohmura; Shuichi Matsuda; Akio Morinobu; Motomu Hashimoto
Journal:  Rheumatol Int       Date:  2022-03-10       Impact factor: 2.631

7.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

8.  Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated.

Authors:  K Youngblood; L Fruchter; G Ding; J Lopez; V Bonagura; A Davidson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG.

Authors:  M M Newkirk; M J Fournier; J Shiroky
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

10.  Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Michael I M Orloff; Eiko Nishiuchi; Svetlana Marukian; Charles M Rice; Lynn B Dustin
Journal:  Arthritis Rheum       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.